Case report: Reversible encephalopathy associated with liposomal amphotericin B in a patient with cryptococcal meningitis
Si Luo, Han Wen, Meihong Zhou and 2 more
Frontiers in Neurology · 2022
doi:10.3389/fneur.2022.1019137 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Liposomal amphotericin B (L-AMB) is an anti-fungus medicine that has fewer side effects than traditional amphotericin B (AMB). Neurotoxicity of L-AMB has rarely been observed, and only one case of leukoencephalopathy during intravenous L-AMB has been reported. Herein, we described a patient with cryptococcal meningitis presenting with late-onset reversible encephalopathy associated with liposomal amphotericin B.
Abstract licence: CC BY
References23
23 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.